Medibank share price sinks on cyber incident and trading update

Medibank shares are starting the week in the red…

| More on:
a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank shares are sinking on Monday
  • This follows news that the private health insurance giant was the victim of a cyber attack
  • Positively, the company doesn't believe that customer data was removed

The Medibank Private Ltd (ASX: MPL) share price has returned from its trading halt and dropped deep into the red.

In morning trade, the private health insurer's shares are down 4.5% to $3.35.

Why is the Medibank share price falling?

Investors have been selling down the Medibank share price today despite the company releasing a positive update on last week's cybersecurity incident.

Last week, Medibank revealed that it detected unusual activity on its network. In response, the company took immediate steps to contain the incident, and engaged specialised cyber security firms.

The good news is that Medibank doesn't believe that any customer data has been removed.

According to the release, ongoing investigations continue to show that there remains no evidence customer data has been removed from its IT environment. As a result, normal operations have resumed. Though, Medibank will continue to investigate the incident as part of its ongoing forensic analysis.

Management notes that as a health company providing health insurance and health services, Medibank holds a range of necessary personal information of customers. In light of this, it stressed that the protection of customers' data security is its highest priority.

As a result, Medibank has deployed additional security measures across its network, strengthening the integrity of its systems.

What actually happened?

At this stage, Medibank's investigation indicates that its cyber security systems had detected activity consistent with the precursor to a ransomware event. This initial finding was shared with the Australian Cyber Security Centre, who provided Medibank with additional guidance in support of this conclusion.

Medibank's systems were not encrypted by ransomware during this incident and there is no indication that the incident was caused by a state-based threat actor.

Trading update

In other news, Medibank has taken this opportunity to provide the market with an update on its performance so far in FY 2023.

Positively, during the three months to 30 September, Medibank has continued to show good momentum and is tracking in line with the FY 2023 outlook provided with its full year results.

Management does not expect this short disruption to impact this momentum.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man holds his head in his hands after seeing bad news on his laptop screen.
Healthcare Shares

Why did CSL shares crash 39% in 2025?

Should you be buying the dip? Let's find out.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »

research with microscope
Healthcare Shares

This ASX healthcare stock just changed its debt. Here's why it matters

Shares in Mesoblast edge higher after the company announces a major change to its debt and funding structure.

Read more »

stock growth chart
Healthcare Shares

Will CSL shares crash again in 2026?

CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Here's the dividend forecast out to 2030 for Sigma shares

This business could pay healthy dividends in the coming years…

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Mayne Pharma signals short-term pain as it resets for growth

It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals.

Read more »

A man packs up a box of belongings at his desk as he prepares to leave the office.
Healthcare Shares

Regis Healthcare shares down 2% as CEO resigns

Dr Mellors will step down as CEO after more than six years in the role.

Read more »